[ Kayla Freeman, DNP, APRN, FNP-C ] The evolving landscape of cancer treatment underscores the need for close collaboration among multidisciplinary teams and enhanced patient education to navigate newly approved therapies effectively.
With the advent of novel treatment options, oncology nurses and advanced practice providers (APPs) must be prepared to educate patients while working within interdisciplinary teams to ensure continuity of care, according to an expert in the field.
Dr Kayla Freeman, DNP, APRN, FNP-C, shared insights with Oncology Nursing News regarding the future of oncology nursing. She highlighted that one of the most significant changes affecting oncology nurses and APPs is the approval of new therapies, particularly immunotherapies.
These advancements necessitate a shift in approach, requiring healthcare professionals to integrate interdisciplinary care strategies to manage potential adverse effects and ensure patients can adhere to treatments for extended periods.
Freeman, who serves as the lead APP for breast oncology at Emory Winship Cancer Institute, emphasised the critical role of patient education in this evolving treatment landscape. She noted that setting clear expectations regarding potential side effects is paramount to improving patient outcomes and treatment adherence.
A Need for Proactive Engagement
Freeman pointed out that the ability to offer patients additional treatment options is a significant breakthrough in oncology. However, the effectiveness of these therapies relies not only on medical advancements but also on the seamless cooperation between healthcare providers.
“Education is going to be the biggest factor,” Freeman stated. “Ensuring that patients understand what to expect, working as a multidisciplinary team, and not hesitating to involve other specialists when managing side effects are crucial in helping patients stay on therapy.”
Expanding the Role of Multidisciplinary Teams
As cancer care continues to evolve, interdisciplinary collaboration will play an increasingly vital role. Oncology nurses, APPs, oncologists, pharmacists, and other specialists must work collectively to tailor treatments to individual patients while addressing the complexities of novel therapies.
Additionally, as immunotherapies and targeted treatments become more prevalent, long-term management strategies must adapt to enhance patient quality of life and mitigate treatment-related challenges.
These changes highlight the necessity of continuous professional education and institutional support to equip healthcare providers with the knowledge and resources needed to navigate an expanding array of treatment options.